Skip to content

Study the effects of atibala churna in raktapradar (menorraghia)

A single arm clinical study to evaluate the effect of atibala churna in the management of raktapradar (menorraghia)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/04/051404
Enrollment
30
Registered
2023-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R651- Systemic inflammatory response syndrome (SIRS) of non-infectious origin

Interventions

None listed

Sponsors

Dr Ravina kamdar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients from age group of 12-50 years Patients with Lakshana of Raktapradar like prolong, excessive menstrual bleeding or intermenstrual bleeding

Exclusion criteria

Exclusion criteria: Patient having other associated complications such as Fibroid, Polyp, Malignancy, Hypertension,Tuberculosis, Diabetes mellitus,inter uterine devices was excluded from study point of view.

Design outcomes

Primary

MeasureTime frame
Effect of Atibala Churna in Raktapradar (Menorraghia)Timepoint: In Raktapradar Patients with 1 Month study with Follow Up on 5 th day 10 th day and on Next Month Menstrual Cycle .

Secondary

MeasureTime frame
To observe the adverse effects of Atibala churna , if anyTimepoint: 4 FOLLOW UPS 1st - day 2 2nd- day 5 3rd- day 10 4TH â?? DURING NEXT

Countries

India

Contacts

Public ContactDR HRIDAYNATH LAD

Dr. D.Y. Patil College OF Ayurveda and Research Centre, Pimpri -Pune

hridaynath.lad@gmail.com9822964454

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026